Investing Profile

Brent Ahrens


General Partner at Canaan Partners Park, California
Photo of Brent Ahrens, General Partner at Canaan Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Canaan Partners General Partner
$250K - $20.0M
CompanyStageDateRound SizeTotal Raised
Grey Wolf Therapeutics
Series AFeb 2019£10M
Unchained Labs
Series CJun 2017$13M
Series AFeb 2015$25M
Iterum Therapeutics
Series BMay 2017$65M
Series AMar 2016$40M
Co-investors: Mark Chin (Arix Bioscience)
Venture RoundDec 2016$10M
Relievant Medsystems
Series DOct 2016$36M
Series DMar 2012$30M
Series CJul 2009$20M
Co-investors: Justin Klein (Vensana Capital), Jason Lettmann (Morgenthaler Ventures)
EndoGastric Solutions
Venture RoundDec 2015$50M
Series GMay 2014$30M
Venture RoundJun 2012$13M
Venture RoundApr 2012$2.1M
Series GMar 2012$11M
Series FAug 2010$30M
Co-investors: Mike Carusi (Lightstone Ventures)
Minimally invasive devices
Series CNov 2015$14M
Debt FinancingJun 2014$6M
Series BJun 2013$2.5M
Series BMar 2013$9M
Co-investors: Wende Hutton (Canaan Partners)
Spinifex Pharmaceuticals
Series CApr 2014$45M
Co-investors: Heath Lukatch (Red Tree Venture Capital)